Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Polyphenon E in Bladder Cancer
NCT00666562Phase 2Completed
- Sponsor
- National Cancer Institute
- Start
- Jul 2008
- Primary completion
- Apr 2012
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 2, randomised, double-blind trial of green tea extract in bladder cancer (3 arms), sponsored by National Cancer Institute. Primary endpoint: Epigallocatechin Gallate (EGCG) Levels in Nonmalignant Bladder Tissue up to 28 days. Started Jul 2008; status: completed.
02
Drugs
green tea extract
03
Conditions
bladder cancer
Beyond the preview
Go deeper on NCT00666562.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00666562.